MedTrace Logo

Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort

NCT02228473 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2014-10-28

No results posted yet for this study

Summary

We want to evaluate the efficacy of the glycopyrrolate and atropine for the prevention of catheter-related bladder discomfort.

Conditions

  • Catheter Site Discomfort
  • Complications
  • Anesthesia
  • Urinary Bladder Neoplasms

Interventions

DRUG

Glycopyrrolate

Glycopyrrolate will be administered.

DRUG

Atropine

Atropine will be administered.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Hee-Pyoung Park, PhD · Seoul National University of Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-02-28
Completion
2015-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02228473 on ClinicalTrials.gov